Once a new drug candidate has been identified, the Technical Research & Development (TRD) group at Novartis evolves the final drug presentation. Moving the project from Chemical to Pharmaceutical Development and to Quality Control, TRD’s task is to hand over a robust process to the commercial production facilities. Although this sounds like a standard task in the pharmaceutical industry, every drug has its own challenges to overcome along the way.
Stay connected by subscribing to our newsletter
SubscribeBy submitting your email, you consent to Novartis AG collecting and processing your email data for Novartis internal use, in accordance with our privacy policy, and by protected technical means.
